English 箭头
Podcast Cover

[The Future of Brain Modification: Neurosurgery, Deep Brain Stimulation, and Treating Compulsive Disorders]-[Dr. Casey Halpern: Biology & Treatments for Compulsive Behaviors & Binge Eating]

Huberman Lab · C1 · 2022-09-26

Health
Or study on the web version

📋 Summary

Pioneering the Future of Brain Modification

In this episode of the Huberman Lab Podcast, Dr. Andrew Huberman hosts Dr. Casey Halpern, a leading neurosurgeon and researcher at the University of Pennsylvania. The discussion centers on the cutting-edge intersection of neurosurgery, neuroscience, and the treatment of debilitating conditions such as binge eating disorder, obsessive-compulsive disorder (OCD), and movement disorders like Parkinson’s disease.

Rethinking Brain Disorders: The "Loss of Control" Spectrum

Dr. Halpern challenges traditional views of psychiatric conditions, suggesting that disorders like OCD, binge eating, and addiction share a common denominator: a "loss of control." He emphasizes that while pharmacologic interventions like SSRIs are helpful, they are systemic and lack the precision required for complex circuit-based pathologies.

Instead, the Halpern Laboratory focuses on deep brain stimulation (DBS) and transcranial focused ultrasound. These engineered devices aim to directly modulate specific neural circuits. By targeting the nucleus accumbens—a critical hub for reward-seeking behavior—Dr. Halpern’s team seeks to interrupt the dysfunctional signaling that drives compulsive eating and obsessions, even when a patient is fully aware of the negative consequences.

The Role of the Nucleus Accumbens

The nucleus accumbens is central to how the brain processes rewards and motivation. Dr. Halpern explains that repeated exposure to highly palatable, high-fat foods or addictive substances can "hijack" this region, leading to persistent cravings. His research utilizes a novel approach: identifying "craving cells" in the operating room. By observing real-time electrical activity while patients are exposed to food cues, the team can pinpoint the exact locations to place electrodes for episodic, responsive stimulation—a technique that aims to restore normal function rather than continuously suppressing activity.

Precision and the "Astronauts of Neuroscience"

Dr. Halpern describes neurosurgeons as the "astronauts of neuroscience" due to the uncharted, high-stakes nature of their work. The precision required is immense; even a two-to-three-millimeter deviation in electrode placement can dictate the success or failure of a therapy.

Key highlights regarding their surgical methodology include:

  • Intraoperative Monitoring: Using electrical signals to identify "tremor cells" or "craving cells" during surgery to ensure optimal placement.
  • Connectomics: Utilizing advanced imaging to map the connections between the nucleus accumbens and the prefrontal cortex, allowing for structurally guided targeting.
  • Responsive Therapy: Moving away from continuous stimulation toward episodic, "closed-loop" systems that deliver stimulation only when specific craving signals are detected, thereby avoiding the tolerance effects often seen in continuous therapy.

The Power of Awareness and Future Directions

Despite the sophistication of these technological interventions, both Huberman and Halpern agree that patient awareness remains a cornerstone of recovery. Dr. Halpern notes that for patients with severe, refractory conditions, awareness alone may not be enough to stop a binge, but it is a vital component of the therapeutic process.

Looking forward, the discussion explores the potential for non-invasive treatments, such as transcranial magnetic stimulation (TMS) and focused ultrasound, to eventually provide scalable solutions for millions of people. While these technologies are currently in development, Dr. Halpern stresses that "we have to get into the brain before we can get out of it," implying that invasive research is necessary to map the circuits that will eventually allow for precise, non-invasive brain modification.

Conclusion

This episode provides a profound look at the future of clinical neuroscience. By shifting from treating the brain as a "chemical soup" to viewing it as a series of modifiable circuits, Dr. Halpern and his colleagues are opening new doors for patients who have exhausted traditional therapies. Whether it is through the meticulous precision of DBS or the potential of machine-learning-assisted diagnostic tools, the field is moving toward a future where brain disorders are addressed with the same rigor and technical sophistication as structural neurological conditions.

🎯Key Sentences

1
Let's talk about your work, past and present.
2
The scope of neurosurgery is quite broad.
3
I have to say, I am amazed by these effects every day.
4
I've never really wanted to do anything else.
5
I see it all the time.
Expand All

📝Key Phrases

1
migrate to
2
leading edge
3
intimately involved in
4
engage in
5
debilitating
Expand All

📖 Transcript

Welcome to the Huberman Lab Podcast, where we discuss science and science-based tools for everyday life.
I'm Andrew Huberman, and I'm a professor of neurobiology and ophthalmology at Stanford School of Medicine.
Today, my guest is Dr. Casey Halpern. Dr. Halpern is the chief of neurosurgery at the University of Pennsylvania School of Medicine.
His laboratory focuses on bulimia, binge eating disorder, and other forms of obsessive compulsive behaviors.
Normally when we hear about eating disorders or obsessive compulsive disorders of other kinds, The conversation quickly migrates to pharmacologic interventions and serotonin or dopamine or talk therapy interventions, many of which can be effective.
The Halpern Laboratory, however, takes an entirely different approach.

ListenLeap Brings You Into Real Context Learning

🎨 Interesting Content
🌍 Real Materials
📱 Listen Anytime
Or study on the web version